Acute 2DG-induced glucoprivation or dexamethasone abolishes 2DG-induced glucoregulatory responses to subsequent glucoprivation

Diabetes

Volumn 50, Issue 12, 2001, Pages 2831-2836

  Sanders, Nicole M ^a   Ritter, Sue ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DEOXYGLUCOSE; DEXAMETHASONE; GLUCOCORTICOID; GLYCOGEN;

ADRENALECTOMY; ANIMAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; DRUG EFFECT; EATING; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HYPOGLYCEMIA; IATROGENIC DISEASE; KINETICS; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RAT STRAIN;

ADRENALECTOMY; ANIMAL; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; DEOXYGLUCOSE; DEXAMETHASONE; EATING; EPINEPHRINE; GLUCOCORTICOIDS; GLUCOCORTICOIDS, SYNTHETIC; GLYCOGEN; HOMEOSTASIS; HYPOGLYCEMIA; KINETICS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035653509     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.12.2831     Document Type: Article

References (36)

1. Fanelli CG, Epifano I, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale R, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689, 1993
2. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA: Restoration of hypoglycemia awareness in patients with long duration insulin-dependent diabetes. Lancet 344:283-287, 1994
3. Powell A, Sherwin RS, Shulman G: Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrent hypoglycemia rats: reversibility and stimulus specificity of the deficits. J Clin Invest 92:2667-2674, 1993
4. Davis S, Shavers C, Mosqueda-Garcia R, Costa F: Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 46:1328-1335, 1997
5. Ovalle R, Fanelli C, Paramore D, Hershey T, Crafe S, Cryer PE: Brief twice weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes. Diabetes 47:1472-1479, 1998
6. Cryer PE: Iatrogenic hypoglycemia as a cause of hypoglycemia associated autonomic failure in IDDM: a vicious cycle. Diabetes 41:255-260, 1992
7. Davis MR, Shamoon H: Counterregulatory adaptation to recurrent hypoglycemia in normal humans. J Clin Endocrinol Metab 73:995-1001, 1991
8. Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. J Clin Invest 91:819-828, 1993
9. Davis S, Shavers C, Costa F, Mosqueda-Garcia R: Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 98:680-691, 1996
10. Arase K, York DA, Bray GA: Corticosterone inhibition of the intracerebroventricular effect of 2-deoxy-D-glucose on brown adipose tissue thermogenesis. Physiol Behav 40:489-495, 1987
11. Davis S, Shavers C, Davis B, Costa F: Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses. J Clin Invest 100:429-438, 1997
12. Saifer A, Gerstenfeld S: The photometric microdetermination of blood glucose with glucose oxidase. J Lab Clin Med 51:445-460, 1958
13. Ritter S, Dinh TT, Llwellyn-Smith I: Subgroups of hindbrain catecholamine neurons are selectively activated by 2-deoxy-D-glucose induced metabolic challenge. Brain Res 805:41-54, 1998
14. Heller SR, Cryer PE: Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-220, 1991
15. The Diabetes Control and Complications Trial Research Group: The effect of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
16. Anouar Y, Eiden LE: Rapid and long-lasting increases in galanin mRNA levels in rat adrenal medulla following insulin-induced reflex splanchnic nerve stimulation. Neuroendocrinology 62:611-618, 1995
17. degli Uberti EC, Ambrosio MR, Bondanelli M, Trasforini G, Valentini A, Rossi R, Margutti A, Campo M: Effect of human galanin on the response of circulating catecholamines to hypoglycemia in man. Eur J Endocrinol 133:723-728, 1995
18. Borg MA, Borg WP, Tamborlane WV, Brines ML, Shulman GI, Sherwin RS: Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes 48:584-587, 1999
19. Tkacs NC, Levin BE: Reduced counterregulation after repeated insulin injections in rats: CNS activation patterns (Abstract). Abstr Soc Neurosci 24:1121A, 1998
20. Sanders NM, Ritter S: Repeated 2DG-induced glucoprivation attenuates fos expression and glucoregulatory responses during subsequent glucoprivation. Diabetes 49:1865-1874, 2000
21. Ritter RC, Roelke M, Neville M: Glucoprivic feeding behavior in absence of other signs glucoprivation. Am J Physiol 234:E617-E621, 1978
22. Bellin S, Ritter S: Disparate effects of infused nutrients on delayed glucoprivic feeding and hypothalamic norepinephrine turnover. J Neurosci 12:1347-1353, 1981
23. Bellin SI, Ritter S: Insulin-induced elevation of hypothalamic norepinephrine turnover persists after glucorestoration unless feeding occurs. Brain Res 217:327-337, 1981
24. Ritter S, Dinh TT, Zhang Y: Localization of hindbrain glucoreceptive sites controlling food intake and blood glucose. Brain Res 21:37-47, 2000
25. Ritter S, Bugarith K, Dinh TT: Immunotoxic destruction of distinct catecholamine subgroups produces selective impairments of glucoregulatory responses and neuronal activation. J Comp Neurol 432:197-216, 2001
26. Ritter S, Dinh TT: 2-Mercaptoacetate and 2-deoxy-D-glucose induce Fos-like immunoreactivity in rat brain. Brain Res 641:111-120, 1994
27. Sanders N, Ritter S: Fos-immunoreactivity in response to insulin-induced hypoglycemia in rat brain (Abstract). Appetite 29:387-421, 1997
28. Sanders N, Ritter: Repeated insulin-induced hypoglycemia abolishes Fos-immunoreactivity during subsequent hypoglycemia (Abstract). Abstr Soc Neurosci 23:2054A, 1997
29. Sawchenko PE, Bohn M: Glucocorticoid receptor immunoreactivity in C1, C2, and C3 adrenergic neurons that project to the hypothalamus or to the spinal cord in the rat. J Comp Neurol 285:107-116, 1985
30. Lachuer J, Buda M, Tappaz M: Differential time course activation of brain stem catecholaminergic groups following chronic adrenalectomy. Neuroendocrinology 56:125-132, 1992
31. Lachuer J, Gailler S, Barbagli B, Buda M, Tappaz M: Differential early time course activation of brainstem catecholaminergic groups in response to various stressors. Neuroendocrinology 53:589-596, 1991
32. Vetrugno G, Lachuer J, Perego C, Miranda E, De Simoni M, Tappaz M: Lack of glucocorticoids sustains the stress-induced release of noradrenaline in the anterior hypothalamus. Neuroendocrinology 57:835-842, 1993
33. Kvetnansky R, Fukuhara K, Pacak K, Cizza G, Goldstein D, Kopin I: Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology 133:1411-1419, 1993
34. Pacak K, Palkovits M, Kvetnansky R, Matern P, Hart C, Kopin IJ, Goldstein DS: Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats. Endocrinology 136:4814-4819, 1995
35. Brown MR, Fisher LA: Glucocorticoid suppression of the sympathetic nervous system and adrenal medulla. Life Sci 39:1003-1012, 1986
36. Sapolsky RM, Romero LM, Munck AU: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89, 2000